RALGPS2
Ras-specific guanine nucleotide-releasing factor RalGPS2
Also known as: FLJ10244, FLJ25604, KIAA0351, RGPS2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86X27
- Gene
- RALGPS2
- Ensembl
- ENSG00000116191
- Chromosome
- 1
- Canonical length
- 583 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in Ras protein signal transduction. Predicted to be located in cytoplasm. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
583 residues, UniProt reviewed canonical sequence.
>Q86X27|RALGPS2
1 MDLMNGQASS VNIAATASEK SSSSESLSDK GSELKKSFDA VVFDVLKVTP EEYAGQITLM
61 DVPVFKAIQP DELSSCGWNK KEKYSSAPNA VAFTRRFNHV SFWVVREILH AQTLKIRAEV
121 LSHYIKTAKK LYELNNLHAL MAVVSGLQSA PIFRLTKTWA LLSRKDKTTF EKLEYVMSKE
181 DNYKRLRDYI SSLKMTPCIP YLGIYLSDLT YIDSAYPSTG SILENEQRSN LMNNILRIIS
241 DLQQSCEYDI PMLPHVQKYL NSVQYIEELQ KFVEDDNYKL SLKIEPGTST PRSAASREDL
301 VGPEVGASPQ SGRKSVAAEG ALLPQTPPSP RNLIPHGHRK CHSLGYNFIH KMNTAEFKSA
361 TFPNAGPRHL LDDSVMEPHA PSRGQAESST LSSGISIGSS DGSELSEETS WPAFERNRLY
421 HSLGPVTRVA RNGYRSHMKA SSSAESEDLA VHLYPGAVTI QGVLRRKTLL KEGKKPTVAS
481 WTKYWAALCG TQLFYYAAKS LKATERKHFK STSNKNVSVI GWMVMMADDP EHPDLFLLTD
541 SEKGNSYKFQ AGNRMNAMLW FKHLSAACQS NKQQVPTNLM TFELocalizationUniProt · AlphaFold · HPA
Whether an antibody against RALGPS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- testis: 67 nTPM
- retina: 50 nTPM
- tonsil: 49 nTPM
- lymph node: 43 nTPM
- liver: 28 nTPM
- spleen: 26 nTPM
Single-cell type
- b-cells: 1,378 nCPM
- rod photoreceptor cells: 824 nCPM
- urothelial cells: 632 nCPM
- plasma cells: 514 nCPM
- esophageal apical cells: 483 nCPM
- cone photoreceptor cells: 458 nCPM
Immune cell
- memory B-cell: 29 nTPM
- naive B-cell: 24 nTPM
- eosinophil: 2.5 nTPM
- neutrophil: 1.4 nTPM
- total PBMC: 1.2 nTPM
- naive CD4 T-cell: 0.9 nTPM
Brain region
- hippocampal formation: 20 nTPM
- hypothalamus: 17 nTPM
- basal ganglia: 15 nTPM
- cerebellum: 15 nTPM
- cerebral cortex: 15 nTPM
- spinal cord: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.26
- gnomAD missense Z
- 2.14
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RALGPS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RALGPS2 as an antibody target. Whether an autoantibody or antibody against RALGPS2 could matter depends on whether native RALGPS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RALGPS2 is annotated at the cell surface, where native RALGPS2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RALGPS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...